Countdown to Amneal (AMRX) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Wall Street analysts expect Amneal Pharmaceuticals (AMRX) to post quarterly earnings of $0.07 per share in its upcoming report, which indicates a year-over-year decline of 69.6%. Revenues are expected to be $630.67 million, up 3.4% from the year-ago quarter.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Before a company an ...